Lord, Abbett & Co
PRCT icon

Lord, Abbett & Co’s Procept Biorobotics PRCT Stock Holding History

Lord, Abbett & Co’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-372,222
Closed -$21.4M – 570
2025
Q2 		$21.4M Sell
372,222
-172,519
-32% -$9.75M 0.07% 272
2025
Q1 		$31.7M Sell
544,741
-80,479
-13% -$5.49M 0.11% 217
2024
Q4 		$50.3M Sell
625,220
-123,335
-16% -$10.5M 0.16% 168
2024
Q3 		$60M Buy
748,555
+233,430
+45% +$16.6M 0.19% 148
2024
Q2 		$31.5M Buy
515,125
+262,815
+104% +$15.6M 0.1% 241
2024
Q1 		$12.5M Buy
252,310
+71,106
+39% +$3.38M 0.04% 371
2023
Q4 		$7.59M Buy
+181,204
New +$6.17M 0.03% 417
2023
Q2 		– Sell
-107,959
Closed -$3.07M – 575
2023
Q1 		$3.07M Sell
107,959
-51,139
-32% -$1.8M 0.01% 506
2022
Q4 		$6.61M Buy
159,098
+886
+0.6% +$38K 0.02% 468
2022
Q3 		$6.56M Buy
158,212
+65,952
+71% +$2.63M 0.02% 445
2022
Q2 		$3.02M Buy
+92,260
New +$3.36M 0.01% 527

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Lord, Abbett & Co's PRCT Position: Q3 2025 in Review

Lord, Abbett & Co sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 372,222 shares — an estimated $21.4M sold.

Lord, Abbett & Co first reported a position in PRCT in Q2 2022 and held it in 11 quarters. The position peaked at $60M in Q3 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Lord, Abbett & Co reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Lord, Abbett & Co sold 372,222 Procept Biorobotics shares in Q3 2025, an estimated $21.4M.
  • Lord, Abbett & Co first reported a position in Procept Biorobotics in Q2 2022 and held it in 11 quarters.
  • Lord, Abbett & Co's Procept Biorobotics position peaked at $60M in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Lord, Abbett & Co's 13F filing for Q3 2025, filed 13 Nov 2025.